BioROSA Technologies

Belmont, United States

BioROSA Technologies creates a biologically-based diagnostic standard of care for Autism Spectrum Disorders.

$745K raised

Nov 2022

Debt Financing

Biotechnology Health Care Life Science Robotics

Top Investors

SOSV Autism Impact Fund SOSV SF & NY (Fka IndieBio)Zoic Capital Bioverge

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BioROSA Technologies

How much funding has BioROSA Technologies raised?

BioROSA Technologies has raised $745K in total funding. The most recent round was Debt Financing. The last funding was announced in November 2022.

Who are BioROSA Technologies's investors?

BioROSA Technologies's investors include SOSV, Autism Impact Fund, SOSV SF & NY (Fka IndieBio), Zoic Capital, Bioverge.

Where is BioROSA Technologies headquartered?

BioROSA Technologies is headquartered in Belmont, United States.

What does BioROSA Technologies do?

BioROSA Technologies creates a biologically-based diagnostic standard of care for Autism Spectrum Disorders.

What stage is BioROSA Technologies at?

BioROSA Technologies is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 22, 2022.

MLA

"BioROSA Technologies — Funding & Investors." VCBacked, November 22, 2022, https://www.vcbacked.co/company/biorosa-technologies. Accessed July 2, 2026.

APA

VCBacked. (2022). BioROSA Technologies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/biorosa-technologies

Wikipedia (cite web)

{{cite web |title=BioROSA Technologies — Funding & Investors |url=https://www.vcbacked.co/company/biorosa-technologies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 22, 2022.